| Trevan Rankin Sedlak, MD | |
|
Knowledge Health 298 Fifth Avenue, Floor 7, New York, NY 10001 | |
| (516) 210-6767 | |
| Not Available |
| Full Name | Trevan Rankin Sedlak |
|---|---|
| Gender | Female |
| Speciality | Family Medicine |
| Location | Knowledge Health 298 Fifth Avenue, Floor 7, New York, New York |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033470844 | NPI | - | NPPES |
| SP01D | Other | FL | FLORIDA BLUE |
| 6056340 | Other | FL | CIGNA |
| 4701991 | Other | FL | AETNA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | ME122973 (Florida) | Primary |
| Entity Name | Millenium Medical Management Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366645376 PECOS PAC ID: 3577656339 Enrollment ID: O20070910000773 |
News Archive
An independent survey of 441 seniors 65 years old and up revealed that 81% do not think Congress will find a long-term solution for physician payments for Medicare in 2011. Further, 89% surveyed believe doctors will stop accepting Medicare patients if a planned 23% cut in Medicare reimbursements for physicians services that was scheduled to go into effect on January 1, 2011 is implemented.
A new noninvasive alternative to colonoscopies is as easy as swallowing a pill. The patient ingests PillCam Colon 2, a capsule containing two miniature cameras on either end. As the capsule travels through the digestive tract, it captures images and wirelessly transmits them to a recorder the patient wears on a belt.
Omthera Pharmaceuticals, Inc., a privately-held emerging specialty pharmaceuticals company, announced today that the first patient has been dosed in its pivotal Phase III EVOLVE (EpanoVa fOr Lowering Very high triglyceridEs) trial for Epanova™, the Company's lead compound for the treatment of patients with very high triglycerides. Epanova is an Omega-3 fatty acid containing a novel formulation of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA).
Studies of technological innovations being presented for the first time at Digestive Disease Week- (DDW) showed increased accuracy coupled with decreased cost, time or invasiveness of gastrointestinal procedures. Use of a new high-definition colonoscope, for example, improved physician confidence in diagnosing small polyps, potentially reducing the amount of polyps sent for pathology analysis and the associated costs.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Trevan Rankin Sedlak, MD 644 Tropical Ave, Davenport, FL 33897-3644 Ph: (828) 320-5689 | Trevan Rankin Sedlak, MD Knowledge Health 298 Fifth Avenue, Floor 7, New York, NY 10001 Ph: (516) 210-6767 |
News Archive
An independent survey of 441 seniors 65 years old and up revealed that 81% do not think Congress will find a long-term solution for physician payments for Medicare in 2011. Further, 89% surveyed believe doctors will stop accepting Medicare patients if a planned 23% cut in Medicare reimbursements for physicians services that was scheduled to go into effect on January 1, 2011 is implemented.
A new noninvasive alternative to colonoscopies is as easy as swallowing a pill. The patient ingests PillCam Colon 2, a capsule containing two miniature cameras on either end. As the capsule travels through the digestive tract, it captures images and wirelessly transmits them to a recorder the patient wears on a belt.
Omthera Pharmaceuticals, Inc., a privately-held emerging specialty pharmaceuticals company, announced today that the first patient has been dosed in its pivotal Phase III EVOLVE (EpanoVa fOr Lowering Very high triglyceridEs) trial for Epanova™, the Company's lead compound for the treatment of patients with very high triglycerides. Epanova is an Omega-3 fatty acid containing a novel formulation of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA).
Studies of technological innovations being presented for the first time at Digestive Disease Week- (DDW) showed increased accuracy coupled with decreased cost, time or invasiveness of gastrointestinal procedures. Use of a new high-definition colonoscope, for example, improved physician confidence in diagnosing small polyps, potentially reducing the amount of polyps sent for pathology analysis and the associated costs.
› Verified 5 days ago
Syra Hanif, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 492 6th Ave, New York, NY 10011 Phone: 646-454-9000 Fax: 646-454-9047 | |
Tahsin Kabir, Family Medicine Medicare: Medicare Enrolled Practice Location: 317 E 34th St, New York, NY 10016 Phone: 212-726-7400 | |
Dr. Sapna Chaudhary, D.O. Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 245 5th Ave, 2nd Floor, New York, NY 10016 Phone: 646-935-2265 Fax: 646-935-2272 | |
Vikrant Khanderia, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 154 W 71st St, New York, NY 10023 Phone: 212-496-4600 Fax: 917-441-0195 | |
Massiel Esther Crespo Fleury, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 160 W 26th St, New York, NY 10001 Phone: 212-924-2510 | |
Sarah Phillips Saltzman, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 230 W 17th St, New York, NY 10011 Phone: 212-206-5200 | |
Dr. Harveen Singh, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 226 W 14th St, New York, NY 10011 Phone: 646-604-1800 Fax: 508-270-1099 |